Abstract
Recent years have witnessed numerous attempts at identifying the biological correlates of impending psychosis. Biochemical markers may theoretically provide a powerful approach to identify at-risk individuals, potentially leading to more effective intervention strategies to treat them. Hopefully, future developments in the field of research biochemistry in patients with at risk mental states or prodromal symptoms will make this approach ideal for screening and monitoring purposes. In this review, we provide an overview of the different biochemical markers which have been recently demonstrated to be altered in the biological fluids of patients with impending psychosis. We will also examine the practical issues that seem to be limiting the effective integration of biomarkers into clinical development.
Keywords: Biomarkers, at risk mental states, prodromal symptoms, psychosis, neurotrophins, oxidative stress, cannabinoids, schizophrenia, Mass spectrometry, cytokines
Current Pharmaceutical Design
Title: Biochemical Markers of Impending Psychosis
Volume: 18 Issue: 4
Author(s): Enzo Emanuele, Valentina Martinelli, Vera Abbiati, Paolo Fusar-Poli and Pierluigi Politi
Affiliation:
Keywords: Biomarkers, at risk mental states, prodromal symptoms, psychosis, neurotrophins, oxidative stress, cannabinoids, schizophrenia, Mass spectrometry, cytokines
Abstract: Recent years have witnessed numerous attempts at identifying the biological correlates of impending psychosis. Biochemical markers may theoretically provide a powerful approach to identify at-risk individuals, potentially leading to more effective intervention strategies to treat them. Hopefully, future developments in the field of research biochemistry in patients with at risk mental states or prodromal symptoms will make this approach ideal for screening and monitoring purposes. In this review, we provide an overview of the different biochemical markers which have been recently demonstrated to be altered in the biological fluids of patients with impending psychosis. We will also examine the practical issues that seem to be limiting the effective integration of biomarkers into clinical development.
Export Options
About this article
Cite this article as:
Emanuele Enzo, Martinelli Valentina, Abbiati Vera, Fusar-Poli Paolo and Politi Pierluigi, Biochemical Markers of Impending Psychosis, Current Pharmaceutical Design 2012; 18 (4) . https://dx.doi.org/10.2174/138161212799316000
DOI https://dx.doi.org/10.2174/138161212799316000 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Targeting of Acid Ceramidase: Implications to Cancer Therapy
Current Drug Targets Purification of Native and Recombinant Cobra Venom Factor Using Thiophilic Adsorption Chromatography
Protein & Peptide Letters Pro-Drugs for Indirect Cannabinoids as Therapeutic Agents
Current Drug Delivery Airway Smooth Muscle Cell as Therapeutic Target of Inflammation
Current Medicinal Chemistry Treatment of Hereditary Angioedema: Current Perspectives
Recent Patents on Inflammation & Allergy Drug Discovery Herb-Drug Interactions: An Evidence Based Approach
Current Medicinal Chemistry Mitigation of Radiation-induced Pneumonitis and Lung Fibrosis using Alpha-lipoic Acid and Resveratrol
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Design, Synthesis and QSAR Studies on a Series of 2, 5-Disubstituted- 1,3,4-oxadiazole Derivatives of Diclofenac and Naproxen for Analgesic and Anti-inflammatory Activity
Medicinal Chemistry Multifunctional Proteins in Tumorigenesis: Aminoacyl-tRNA Synthetases and Translational Components
Current Proteomics Introduction: P2 Receptors
Current Topics in Medicinal Chemistry The Effects of Mesenchymal Stem Cells in Craniofacial Tissue Engineering
Current Stem Cell Research & Therapy Current Evidence and Future Perspectives on Anti-platelet and Statin Pharmacotherapy for Patients with Symptomatic Peripheral Arterial Disease
Current Vascular Pharmacology Nutrition in Adult Patients with Inflammatory Bowel Disease
Current Drug Targets Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer’s Disease
Current Alzheimer Research Hetero Oxa-Claisen Rearrangement: Perspective on New Synthetic Pathways and Structures
Current Organic Synthesis Protein-mediated Fatty Acid Uptake in the Heart
Current Cardiology Reviews Subject Index to Volume 2
Current Medicinal Chemistry - Anti-Infective Agents DIMming Ovarian Cancer Growth
Current Drug Targets Epigenetics in Vascular Disease – Therapeutic Potential of New Agents
Current Vascular Pharmacology Emerging Therapeutic Approaches Based on Nanotechnology for the Treatment of Diseases Associated with Telomere Dysfunction
Mini-Reviews in Medicinal Chemistry